These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14603058)

  • 1. Three-dimensional reconstruction of immunolabeled neuromuscular junctions in the human thyroarytenoid muscle.
    Sheppert AD; Spirou GA; Berrebi AS; Garnett JD
    Laryngoscope; 2003 Nov; 113(11):1973-6. PubMed ID: 14603058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional computer reconstruction of the distribution of neuromuscular junctions in the thyroarytenoid muscle.
    Rosen M; Malmgren LT; Gacek RR
    Ann Otol Rhinol Laryngol; 1983; 92(5 Pt 1):424-9. PubMed ID: 6625438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
    Kendall KA; Leonard RJ
    J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngeal Botulinum Toxin Injection for Vocal Tremor: Utility of Concurrent Strap Muscle Injection.
    Nelson RC; Silva Merea V; Tierney WS; Milstein C; Benninger MS; Bryson PC
    Laryngoscope; 2019 Jun; 129(6):1433-1437. PubMed ID: 30588631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
    Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
    Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoral electromyographic recordings in botulinum toxin-injected rat larynges.
    Inagi K; Rodriquez AA; Ford CN; Heisey DM
    Ann Otol Rhinol Laryngol; 1997 Nov; 106(11):956-64. PubMed ID: 9373087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report.
    Warrick P; Dromey C; Irish J; Durkin L
    J Voice; 2000 Sep; 14(3):410-21. PubMed ID: 11021508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cricothyroid and thyroarytenoid muscle botulinum toxin injection on patients with dyspnea caused by bilateral recurrent laryngeal nerve paresis].
    Xu XL; Lai JM; Qiu T; Ma YL; Jiao YC; Zhuang PY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):375-380. PubMed ID: 29764020
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botox treatment in adductor spasmodic dysphonia: a meta-analysis.
    Boutsen F; Cannito MP; Taylor M; Bender B
    J Speech Lang Hear Res; 2002 Jun; 45(3):469-81. PubMed ID: 12069000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of patient factors on response outcomes to Botox treatment of spasmodic dysphonia.
    Lundy DS; Lu FL; Casiano RR; Xue JW
    J Voice; 1998 Dec; 12(4):460-6. PubMed ID: 9988033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal dystonia: case report and treatment with botulinum toxin.
    Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
    Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin injection and airflow stability in spasmodic dysphonia.
    Cantarella G; Berlusconi A; Maraschi B; Ghio A; Barbieri S
    Otolaryngol Head Neck Surg; 2006 Mar; 134(3):419-23. PubMed ID: 16500438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional computer reconstruction of the neuromuscular junction distribution in the human posterior cricoarytenoid muscle.
    Gambino DR; Malmgren LT; Gacek RR
    Laryngoscope; 1985 May; 95(5):556-60. PubMed ID: 3990485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spasmodic dysphonia combined with insufficient glottic closure by phonation.
    Kaszás Z; Lichtenberger G; Mészáros K; Falvai J
    Eur Arch Otorhinolaryngol; 2003 Sep; 260(8):418-20. PubMed ID: 12709812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
    van Esch BF; Wegner I; Stegeman I; Grolman W
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia.
    Bielamowicz S; Stager SV; Badillo A; Godlewski A
    J Voice; 2002 Mar; 16(1):117-23. PubMed ID: 12002878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tremor laryngeal dystonia: treatment of the lateral cricoarytenoid muscle.
    Maronian NC; Waugh PF; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):349-55. PubMed ID: 15174760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia.
    Lerner MZ; Lerner BA; Patel AA; Blitzer A
    Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.